Brooks to Participate in the 20th Annual Needham Virtual Healthcare Conference

CHELMSFORD, Mass., April 5, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 which includes a 40-minute webcast beginning at 12:45 p.m. ET.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events.  A... Read more

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19 WALTHAM, Mass. – April 1, 2021 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISATM assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2,... Read more

Horizon Discovery Extends Gene Modulation Portfolio with Industry First Synthetic Single Guide RNA and Patent Pending dCas9 Repressor for CRISPR Interference

CRISPRi Innovations Provide Expanded Experimental Options and Flexibility For Researchers Facilitating Disease & Drug Research WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 29, 2021– Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists... Read more

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif., March 25, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug... Read more

GE Healthcare Announces 510(k) Clearance of New 3D Surgical Imaging System, Enabling More Precise and Efficient Care

New 3D/2D surgical imaging system, OEC 3D, brings precise 3D and 2D imaging to surgical suites improving efficiency Salt Lake City – March 23, 2021 – GE Healthcare today announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. OEC 3D will set a standard... Read more

Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution

Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution Collaboration agreement between Thermo Fisher Scientific and Artificial enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency TORONTO, March 23, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation... Read more

Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics

Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON–(BUSINESS WIRE)– Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D... Read more

Roche launches SARS-CoV-2 variant test to help monitor emerging coronavirus mutations

The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission Accurate detection and differentiation of SARS-CoV-2 mutations can help assess the spread of circulating variants and monitor their potential impact on therapeutics, vaccines and public health interventions Periodic assessments against emerging variants have... Read more

Educational Outreach to the Visually Impaired

From scanning electron microscopy data to tactile teaching tools In 2017, Dr. Alex Ball, head of Imaging and Analysis at the Natural History Museum London (NHM), approached ZEISS with an intriguing idea. What if one could take 3D microscopy data sets and create tangible objects using 3D printers? This would create a physical teaching object... Read more